• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒(HPV)检测和巴氏试验在宫颈癌筛查三年随访中的预测能力

Predictive Capability of HPV and Pap Tests in Screening for Cervical Cancer over a Three-Year Follow-up.

作者信息

Girianelli Vania Reis, Thuler Luiz Claudio Santos, Azevedo e Silva Gulnar

机构信息

Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, RJ, Brazil.

Universidade Federal do Estado do Rio de Janeiro, UNIRIO, Rio de Janeiro, RJ, Brazil.

出版信息

Rev Bras Ginecol Obstet. 2016 Mar;38(3):147-53. doi: 10.1055/s-0036-1580712. Epub 2016 Mar 29.

DOI:10.1055/s-0036-1580712
PMID:27022786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10309360/
Abstract

PURPOSE

To compare the predictive capability of HPV and Pap smear tests for screening pre-cancerous lesions of the cervix over a three-year follow-up, in a population of users of the Brazilian National Health System (SUS).

METHODS

This is a retrospective cohort study of 2,032 women with satisfactory results for Pap smear and HPV tests using second-generation hybrid capture, made in a previous study. We followed them for 36 months with data obtained from medical records, the Cervix Cancer Information System (SISCOLO), and the Mortality Information System (SIM). The outcome was a histological diagnosis of cervical intraepithelial neoplasia grade 2 or more advanced lesions (CIN2+). We constructed progression curves of the baseline test results for the period, using the Kaplan-Meier method, and estimated sensitivity, specificity, positive and negative predictive value, and positive and negative likelihood ratios for each test.

RESULTS

A total of 1,440 women had at least one test during follow-up. Progression curves of the baseline test results indicated differences in capability to detect CIN2+ (p < 0.001) with significantly greater capability when both tests were abnormal, followed by only a positive HPV test. The HPV test was more sensitive than the Pap smear (88.7% and 73.6%, respectively; p < 0.05) and had a better negative likelihood ratio (0.13 and 0.30, respectively). Specificity and positive likelihood ratio of the tests were similar.

CONCLUSIONS

These findings corroborate the importance of HPV test as a primary cervical cancer screening.

摘要

目的

在巴西国家卫生系统(SUS)的使用者群体中,比较人乳头瘤病毒(HPV)检测和巴氏涂片检测在三年随访期内筛查宫颈癌前病变的预测能力。

方法

这是一项回顾性队列研究,研究对象为2032名在之前一项研究中进行第二代杂交捕获法HPV检测和巴氏涂片检测且结果满意的女性。我们通过医疗记录、宫颈癌信息系统(SISCOLO)和死亡信息系统(SIM)获取的数据,对她们进行了36个月的随访。结局指标是宫颈上皮内瘤变2级或更高级别病变(CIN2+)的组织学诊断。我们使用Kaplan-Meier方法构建了该时期基线检测结果的进展曲线,并估计了每项检测的敏感性、特异性、阳性和阴性预测值以及阳性和阴性似然比。

结果

共有1440名女性在随访期间至少进行了一次检测。基线检测结果的进展曲线表明,在检测CIN2+方面存在差异(p < 0.001),当两项检测均异常时检测能力显著更强,其次是仅HPV检测呈阳性。HPV检测比巴氏涂片更敏感(分别为88.7%和73.6%;p < 0.05),且阴性似然比更好(分别为0.13和0.30)。两项检测的特异性和阳性似然比相似。

结论

这些发现证实了HPV检测作为宫颈癌初筛的重要性。

相似文献

1
Predictive Capability of HPV and Pap Tests in Screening for Cervical Cancer over a Three-Year Follow-up.人乳头瘤病毒(HPV)检测和巴氏试验在宫颈癌筛查三年随访中的预测能力
Rev Bras Ginecol Obstet. 2016 Mar;38(3):147-53. doi: 10.1055/s-0036-1580712. Epub 2016 Mar 29.
2
Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.5699名经组织学诊断为宫颈上皮内瘤变2/3级的女性之前的巴氏涂片检查和杂交捕获2代人乳头瘤病毒检测结果。
J Am Soc Cytopathol. 2019 Jul-Aug;8(4):206-211. doi: 10.1016/j.jasc.2019.01.004. Epub 2019 Jan 18.
3
Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.墨西哥莫雷洛斯州基于人乳头瘤病毒(HPV)检测与巴氏涂片用于宫颈癌筛查的比较。
Cancer Causes Control. 2003 Aug;14(6):505-12. doi: 10.1023/a:1024806707399.
4
Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.通过PreTect HPV-proofer和共识PCR检测HPV mRNA和DNA时预测CIN2+:对非典型鳞状细胞意义不明确(ASCUS)或低度鳞状上皮内病变(LSIL)巴氏涂片女性的两年随访。
Int J Cancer. 2005 May 10;114(6):973-6. doi: 10.1002/ijc.20839.
5
Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.对细胞学 LSIL 女性进行 cervista 和 aptima 高危型 HPV 检测的即刻组织病理随访。
Cancer Cytopathol. 2018 Aug;126(8):525-532. doi: 10.1002/cncy.22017. Epub 2018 May 24.
6
Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.高危型人乳头瘤病毒 DNA 检测作为宫颈癌筛查计划中的主要检测方法:一项基于人群的队列研究。
BJOG. 2013 Sep;120(10):1260-7; discussion 1267-8. doi: 10.1111/1471-0528.12272. Epub 2013 Jun 21.
7
Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.高级别宫颈上皮内瘤变治疗后复发的预测:人乳头瘤病毒检测及锥切时年龄的作用
BJOG. 2006 Nov;113(11):1303-7. doi: 10.1111/j.1471-0528.2006.01063.x. Epub 2006 Sep 15.
8
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.人乳头瘤病毒检测用于子宫颈异常初步筛查的评估:敏感性、特异性及转诊频率的比较
JAMA. 2002 Oct 9;288(14):1749-57. doi: 10.1001/jama.288.14.1749.
9
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.基线细胞学检查、人乳头瘤病毒检测与宫颈肿瘤发生风险:一项10年队列分析
J Natl Cancer Inst. 2003 Jan 1;95(1):46-52. doi: 10.1093/jnci/95.1.46.
10
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.识别患有宫颈肿瘤的女性:对巴氏涂片结果不明确者使用人乳头瘤病毒DNA检测
JAMA. 1999 May 5;281(17):1605-10. doi: 10.1001/jama.281.17.1605.

引用本文的文献

1
Opportunities to advance cervical cancer prevention and care.推进宫颈癌预防与护理的机遇。
Tumour Virus Res. 2024 Dec;18:200292. doi: 10.1016/j.tvr.2024.200292. Epub 2024 Oct 25.
2
A Preliminary Study on Exploring a potential Ultrasound Method for Predicting Cervical Cancer.探索一种预测宫颈癌潜在超声方法的初步研究。
J Cancer. 2022 Jan 1;13(3):793-799. doi: 10.7150/jca.60413. eCollection 2022.

本文引用的文献

1
Comparison of adenocarcinoma (ACA) and squamous cell carcinoma (SCC) of the uterine cervix in a sub-optimally screened cohort: a population-based epidemiologic study of 51,842 women in Brazil.筛查欠佳队列中子宫颈腺癌(ACA)与鳞状细胞癌(SCC)的比较:一项基于巴西51842名女性的人群流行病学研究。
Gynecol Oncol. 2014 Nov;135(2):292-6. doi: 10.1016/j.ygyno.2014.08.014. Epub 2014 Aug 14.
2
Cervical cancer-related knowledge, attitudes, and practices of health professionals working in brazil's network of primary care units.巴西基层医疗单位网络中卫生专业人员的宫颈癌相关知识、态度和行为
Oncologist. 2014 Apr;19(4):375-82. doi: 10.1634/theoncologist.2013-0318. Epub 2014 Mar 25.
3
Diagnostic accuracy measures.诊断准确性测量。
Cerebrovasc Dis. 2013;36(4):267-72. doi: 10.1159/000353863. Epub 2013 Oct 16.
4
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.人乳头瘤病毒检测与重复细胞学检查用于轻度宫颈细胞学病变的分流
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2.
5
A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening.系统评价评估人乳头瘤病毒检测在宫颈癌筛查中的随机试验。
Am J Obstet Gynecol. 2013 May;208(5):343-53. doi: 10.1016/j.ajog.2012.11.013. Epub 2012 Nov 15.
6
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.在常规临床实践中同时进行人乳头瘤病毒和宫颈细胞学检测的女性宫颈癌风险:一项基于人群的研究。
Lancet Oncol. 2011 Jul;12(7):663-72. doi: 10.1016/S1470-2045(11)70145-0. Epub 2011 Jun 16.
7
[Prevalence of HPV infection among women covered by the family health program in the Baixada Fluminense, Rio de Janeiro, Brazil].[巴西里约热内卢弗卢米嫩塞低地家庭健康计划覆盖女性中的人乳头瘤病毒(HPV)感染患病率]
Rev Bras Ginecol Obstet. 2010 Jan;32(1):39-46. doi: 10.1590/s0100-72032010000100007.
8
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.人乳头瘤病毒检测在宫颈癌及宫颈上皮内瘤变筛查中的作用:一项随机对照试验。
Lancet Oncol. 2010 Mar;11(3):249-57. doi: 10.1016/S1470-2045(09)70360-2. Epub 2010 Jan 18.
9
HPV screening for cervical cancer in rural India.印度农村地区宫颈癌的人乳头瘤病毒筛查
N Engl J Med. 2009 Apr 2;360(14):1385-94. doi: 10.1056/NEJMoa0808516.
10
Human papillomavirus and Papanicolaou tests to screen for cervical cancer.人乳头瘤病毒和巴氏涂片检查用于宫颈癌筛查。
N Engl J Med. 2007 Oct 18;357(16):1589-97. doi: 10.1056/NEJMoa073204.